96 related articles for article (PubMed ID: 1879971)
1. Synergistic anti-tumor effects of combined IL-1/IFN-alpha/beta therapy in mice injected with metastatic Friend erythroleukemia cells.
Belardelli F; Gabriele L; Proietti E; Sestili P; Peretti M; Rozera C; Gresser I
Int J Cancer; 1991 Sep; 49(2):274-8. PubMed ID: 1879971
[TBL] [Abstract][Full Text] [Related]
2. Combined interleukin 1/interleukin 2 therapy of mice injected with highly metastatic Friend leukemia cells: host antitumor mechanisms and marked effects on established metastases.
Ciolli V; Gabriele L; Sestili P; Varano F; Proietti E; Gresser I; Testa U; Montesoro E; Bulgarini D; Mariani G
J Exp Med; 1991 Feb; 173(2):313-22. PubMed ID: 1671080
[TBL] [Abstract][Full Text] [Related]
3. Sensitized T lymphocytes render DBA/2 beige mice responsive to IFN alpha/beta therapy of Friend erythroleukemia visceral metastases.
Kaido T; Gresser I; Maury C; Maunoury MT; Vignaux F; Belardelli F
Int J Cancer; 1993 May; 54(3):475-81. PubMed ID: 8509222
[TBL] [Abstract][Full Text] [Related]
4. Interaction of IFN alpha/beta with host cells essential to the early inhibition of Friend erythroleukemia visceral metastases in mice.
Gresser I; Kaido T; Maury C; Woodrow D; Moss J; Belardelli F
Int J Cancer; 1994 May; 57(4):604-11. PubMed ID: 8181864
[TBL] [Abstract][Full Text] [Related]
5. Anti-tumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant Friend erythroleukemia cells. VIII. Role of the immune system in the inhibition of visceral metastases.
Gresser I; Maury C; Carnaud C; De Maeyer E; Maunoury MT; Belardelli F
Int J Cancer; 1990 Sep; 46(3):468-74. PubMed ID: 2394514
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of mouse alpha/beta-interferon of the multiplication of alpha/beta-interferon-resistant Friend erythroleukemia cells cocultured with mouse hepatocytes.
Yasui H; Proietti E; Vignaux F; Eid P; Gresser I
Cancer Res; 1990 Jun; 50(12):3533-9. PubMed ID: 2140290
[TBL] [Abstract][Full Text] [Related]
7. Anti-tumor effects of interleukin-2 and interleukin-1 in mice transplanted with different syngeneic tumors.
Belardelli F; Ciolli V; Testa U; Montesoro E; Bulgarini D; Proietti E; Borghi P; Sestili P; Locardi C; Peschle C
Int J Cancer; 1989 Dec; 44(6):1108-16. PubMed ID: 2606579
[TBL] [Abstract][Full Text] [Related]
8. The essential role of endogenous IFN alpha/beta in the anti-metastatic action of sensitized T lymphocytes in mice injected with Friend erythroleukemia cells.
Gresser I; Maury C; Kaido T; Bandu MT; Tovey MG; Maunoury MT; Fantuzzi L; Gessani S; Greco G; Belardelli F
Int J Cancer; 1995 Nov; 63(5):726-31. PubMed ID: 7591292
[TBL] [Abstract][Full Text] [Related]
9. Isolation and characterization of a metastatic Eb-like tumor variant highly responsive to interleukin (IL)-2 and to combination cytokine therapy with IL-2/IL-1 beta and IL-1 beta/interferon-alpha/beta.
Gabriele L; Proietti E; Greco G; Venditti M; Gresser I; Schirrmacher V; Von Hoegen P; Testa U; Modesti A; Cianfriglia M
Invasion Metastasis; 1993; 13(3):147-62. PubMed ID: 8112975
[TBL] [Abstract][Full Text] [Related]
10. Host humoral and cellular immune mechanisms in the continued suppression of Friend erythroleukemia metastases after interferon alpha/beta treatment in mice.
Gresser I; Carnaud C; Maury C; Sala A; Eid P; Woodrow D; Maunoury MT; Belardelli F
J Exp Med; 1991 May; 173(5):1193-203. PubMed ID: 2022926
[TBL] [Abstract][Full Text] [Related]
11. Alpha 1-interferon gene transfer into metastatic Friend leukemia cells abrogated tumorigenicity in immunocompetent mice: antitumor therapy by means of interferon-producing cells.
Ferrantini M; Proietti E; Santodonato L; Gabriele L; Peretti M; Plavec I; Meyer F; Kaido T; Gresser I; Belardelli F
Cancer Res; 1993 Mar; 53(5):1107-12. PubMed ID: 8439955
[TBL] [Abstract][Full Text] [Related]
12. Host CD4+ T lymphocytes are required for the synergistic action of interferon-alpha/beta and adoptively transferred immune cells in the inhibition of visceral ESb metastases.
Kaido TJ; Maury C; Gresser I
Cancer Res; 1995 Dec; 55(24):6133-9. PubMed ID: 8521404
[TBL] [Abstract][Full Text] [Related]
13. Interferon treatment markedly inhibits the development of tumor metastases in the liver and spleen and increases survival time of mice after intravenous inoculation of Friend erythroleukemia cells.
Gresser I; Maury C; Woodrow D; Moss J; Grütter MG; Vignaux F; Belardelli F; Maunoury MT
Int J Cancer; 1988 Jan; 41(1):135-42. PubMed ID: 3422071
[TBL] [Abstract][Full Text] [Related]
14. Local and systemic response of mice to interferon-alpha 1-transfected Friend leukemia cells.
Gabriele L; Kaido T; Woodrow D; Moss J; Ferrantini M; Proletti E; Santodonato L; Rozera C; Maury C; Belardelli F
Am J Pathol; 1995 Aug; 147(2):445-60. PubMed ID: 7639337
[TBL] [Abstract][Full Text] [Related]
15. Cure of mice with established metastatic friend leukemia cell tumors by a combined therapy with tumor cells expressing both interferon-alpha 1 and herpes simplex thymidine kinase followed by ganciclovir.
Santodonato L; Ferrantini M; Gabriele L; Proietti E; Venditti M; Musiani P; Modesti A; Modica A; Lupton SD; Belardelli F
Hum Gene Ther; 1996 Jan; 7(1):1-10. PubMed ID: 8825863
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of mouse interferon alpha/beta compared to single-agent chemotherapy in increasing survival time of mice after intravenous inoculation of Friend erythroleukemia cells.
Gresser I; Maury C; Belardelli F; Maunoury MT; Machover D
J Natl Cancer Inst; 1988 Mar; 80(2):126-31. PubMed ID: 3422696
[TBL] [Abstract][Full Text] [Related]
17. Anti-tumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant Friend leukemia cells. V. Comparisons with the action of tumor necrosis factor.
Gresser I; Belardelli F; Tavernier J; Fiers W; Podo F; Federico M; Carpinelli G; Duvillard P; Prade M; Maury C
Int J Cancer; 1986 Nov; 38(5):771-8. PubMed ID: 3464571
[TBL] [Abstract][Full Text] [Related]
18. Antibody to mouse interferon alpha/beta abrogates resistance to the multiplication of Friend erythroleukemia cells in the livers of allogeneic mice.
Gresser I; Maury C; Vignaux F; Haller O; Belardelli F; Tovey MG
J Exp Med; 1988 Oct; 168(4):1271-91. PubMed ID: 3171480
[TBL] [Abstract][Full Text] [Related]
19. Antitumor effect of thymosin alpha 1/interleukin-2 or thymosin alpha 1/interferon alpha,beta following cyclophosphamide in mice injected with highly metastatic Friend erythroleukemia cells.
Garaci E; Pica F; Mastino A; Palamara AT; Belardelli F; Favalli C
J Immunother Emphasis Tumor Immunol; 1993 Jan; 13(1):7-17. PubMed ID: 8435433
[TBL] [Abstract][Full Text] [Related]
20. Anti-tumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant Friend leukemia cells. VI. Adjuvant therapy after surgery in the inhibition of liver and spleen metastases.
Gresser I; Maury C; Belardelli F
Int J Cancer; 1987 Jun; 39(6):789-92. PubMed ID: 2438237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
